March 2017: GnRH analogue as sole luteal support in IVF

Journal Club Global

0
0
Upvote 0 Comment

Ita Bar-Hava, M.D. (Center from A to Z Fertility in Tel Aviv, Israel), and Moran Blueshtein, Ph.D. (UT Dallas), authors of "Gonadotropin-releasing hormone analogue as sole luteal support in antagonist-based assisted reproductive technology cycles," join experts in the field to discuss an alternative approach to luteal support in IVF:

  • How can a GnRH agonist provide luteal support for patients undergoing IVF
  • What are the advantages and disadvantages of luteal support with intranasal GnRH-a?
  • What is the success rate for intranasal GnRH-a luteal support compared to standard progesterone supplementation?
  • Can this novel approach to luteal support replace the use of progesterone?

The event is presented by Elizabeth Ginsburg, M.D., and the REI program at Brigham and Women’s Hospital.  Expert discussants include Eric Levens, M.D., Valerie Baker, M.D., and Karl Hansen, M.D., Ph.D. The Journal Club Global is hosted by Fertility and Sterility's Video and Media Editor, Kurt Barnhart, M.D., M.S.C.E. at the University of Pennsylvania.

Register to view the discussion here: http://www.workcast.com/register?cpak=5948475532149709

Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.